Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-12-18
pubmed:abstractText
Therapeutic angiogenesis using autologous stem/progenitor cells represents a novel strategy for severe ischemic diseases. Recent reports indicated that adipose tissues could supply adipose-derived regenerative cells (ADRCs). Accordingly, we examined whether implantation of ADRCs would augment ischemia-induced angiogenesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1524-4636
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
61-6
pubmed:meshHeading
pubmed-meshheading:18974384-Adipocytes, pubmed-meshheading:18974384-Adipose Tissue, pubmed-meshheading:18974384-Animals, pubmed-meshheading:18974384-Cell Culture Techniques, pubmed-meshheading:18974384-Cell Differentiation, pubmed-meshheading:18974384-Chemokine CXCL12, pubmed-meshheading:18974384-Disease Models, Animal, pubmed-meshheading:18974384-Flow Cytometry, pubmed-meshheading:18974384-Genes, Reporter, pubmed-meshheading:18974384-Hindlimb, pubmed-meshheading:18974384-Ischemia, pubmed-meshheading:18974384-Leukocytes, Mononuclear, pubmed-meshheading:18974384-Mice, pubmed-meshheading:18974384-Mice, Inbred C57BL, pubmed-meshheading:18974384-Mice, Transgenic, pubmed-meshheading:18974384-Neovascularization, Pathologic, pubmed-meshheading:18974384-RNA, Messenger, pubmed-meshheading:18974384-Regeneration, pubmed-meshheading:18974384-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:18974384-Vascular Endothelial Growth Factor A
pubmed:year
2009
pubmed:articleTitle
Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis.
pubmed:affiliation
Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550 Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't